Thomas Hofmarcher

Dr Thomas Hofmarcher is an Austrian health economist and research director at the Swedish Institute for Health Economics (IHE). He is an expert in the health economics of cancer and cancer policy.

His main research areas are the economic burden of cancer, the value of patient access to new cancer medicines, and policy-oriented analysis of interventions to improve patient access to high-quality and cost-effective cancer care. His primary focus lies in the comparative analysis of cancer care systems around the world, with vast experience in Europe, the Asia-Pacific region, the Middle East and Africa, and Latin America. He has advised the European Commission and the OECD in their work with Europe’s Beating Cancer Plan, co-authored the OECD Country Cancer Profile 2025 for Sweden, is a lead author of a recent OECD report on cancer medicines, and provided data to the European Cancer Inequalities Registry.

He earned his PhD in Economics from Lund University.